GON(SZ:002768)2023-06-02 16:00Financial Performance - The company's operating revenue for 2022 was approximately ¥13.41 billion, representing a 37.28% increase compared to ¥9.77 billion in 2021[6]. - The net profit attributable to shareholders for 2022 was approximately ¥663.11 million, a slight increase of 3.14% from ¥642.94 million in 2021[6]. - The total profit reached 784 million yuan, growing by 5.50% compared to the previous year[60]. - Total revenue for 2022 reached ¥13,406,439,368, a year-on-year increase of 37.28% compared to ¥9,765,988,975.7 in 2021[76]. - Health industry revenue surged by 85.77% to ¥937,890,838.57 from ¥504,877,100.88 in 2021, representing 7.00% of total revenue[76]. - The gross profit margin improved to 35%, up from 30% in the previous year, reflecting better cost management[158]. Cash Flow and Investments - The cash flow from operating activities decreased by 31.96% to approximately ¥359.22 million in 2022, down from ¥527.98 million in 2021[6]. - The company achieved a total operating cash inflow of CNY 14.90 billion in 2022, representing a 46.28% increase compared to CNY 10.19 billion in 2021[92]. - The total operating cash outflow was CNY 14.54 billion in 2022, which is a 50.56% increase from CNY 9.66 billion in 2021[92]. - The net cash flow from investing activities was -831,674,790.36, showing an improvement of 18.58% compared to the previous year[93]. - The total investment amount for the reporting period was 265,508,530.00, a decrease of 78.05% compared to the previous year[102]. Dividends and Shareholder Information - The company plans to distribute a cash dividend of 2.5 CNY per 10 shares (including tax) to all shareholders based on the 2022 profit distribution plan[4]. - The cash dividend accounted for 100% of the total profit distribution amount[185]. - The annual shareholders meeting had a participation rate of 54.76% on May 17, 2022[145]. - The company reported a total of 126,000 shares held by the current directors as of July 31, 2023[146]. Research and Development - The company has over 190 ongoing R&D projects, ensuring continuous innovation in product development[47]. - Research and development (R&D) investment amounted to CNY 386.39 million in 2022, a 37.67% increase from CNY 280.65 million in 2021[90]. - The number of R&D personnel increased to 547 in 2022, up 38.48% from 395 in 2021[90]. - The company is developing organic polymer modified materials for applications in the new energy sector, including lithium battery separators and flame-retardant materials[117]. Market Expansion and Strategic Initiatives - The company is expanding into the health and wellness sector through its subsidiary Dongbao Biological, which offers a range of health-related products[33]. - The company is focusing on expanding its presence in the new energy vehicle market, capitalizing on the transformation of energy consumption[51]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[164]. - A strategic acquisition of a local competitor is in progress, expected to enhance the company's production capacity by 30%[165]. Risk Management - The company has reported a comprehensive risk assessment in the management discussion and analysis section, highlighting potential future risks and corresponding countermeasures[4]. - The company is exposed to raw material price fluctuations, particularly in the lightweight materials sector, which could impact production costs due to rising oil prices[130]. - The company will continue to enhance internal management and strengthen budget control to mitigate the adverse effects of raw material cost fluctuations[133]. Governance and Management - The company has established a clear governance structure, including a shareholders' meeting, board of directors, and supervisory board, to ensure compliance with legal requirements and effective decision-making[188]. - The management structure includes a general manager responsible for major business decisions, supported by vice presidents and other senior management[189]. - The company has been expanding its management team, with recent appointments aimed at enhancing operational efficiency and strategic direction[149][157]. Environmental Responsibility - The company complied with various environmental protection laws and regulations during its operations[197]. - The company holds valid pollution discharge permits for its subsidiaries, with expiration dates ranging from 2023 to 2028[198]. - The company is committed to environmental responsibility and adheres to industry standards for pollution control[197].